Folic acid supplementation normalizes the endothelial progenitor cell transcriptome of patients with type 1 diabetes: a case-control pilot study. - Wikidata - wikimedia - TriplyDB

Folic acid supplementation normalizes the endothelial progenitor cell transcriptome of patients with type 1 diabetes: a case-control pilot study.

Folic acid supplementation normalizes the endothelial progenitor cell transcriptome of patients with type 1 diabetes: a case-control pilot study.

http://www.wikidata.org/entity/Q37337753

about

Regulation of EPCs: The Gateway to Blood Vessel Formation Biomarkers of Nutrition for Development-Folate Review Nutrigenomics in human intervention studies: current status, lessons learned and future perspectives.Grain and bean lysates improve function of endothelial progenitor cells from human peripheral blood: involvement of the endogenous antioxidant defenses.Systems Epidemiology: A New Direction in Nutrition and Metabolic Disease Research Relation between the frequency of CD34⁺ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes.Ascorbic acid blocks hyperglycemic impairment of endothelial function in adolescents with type 1 diabetes Effects of glucose control and variability on endothelial function and repair in adolescents with type 1 diabetes.Tissue Non-Specific Genes and Pathways Associated with Diabetes: An Expression Meta-Analysis.Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.Transcriptome meta-analysis of peripheral lymphomononuclear cells indicates that gestational diabetes is closer to type 1 diabetes than to type 2 diabetes mellitus.Effect of folic acid supplementation during pregnancy on gestational hypertension/preeclampsia: A systematic review and meta-analysis.Multimodal Assessment of Mesenchymal Stem Cell Therapy for Diabetic Vascular Complications.Temporal endogenous gene expression profiles in response to polymer-mediated transfection and profile comparison to lipid-mediated transfection.

P2860

Q21284530-ADA4DF3F-9A01-49D5-B44A-5F4017694D20 Q26785463-BB3FD21D-8A18-4FA3-97BF-184A9DCDEF5A Q33807303-6E7D62E8-D660-47FF-8F55-EA92A93B5968 Q34361728-2117EBF7-352A-4C53-B5A2-221657B0E2E6 Q34388081-C2E2F1C9-95AD-46B1-BB94-E58F80A5D4E2 Q35607738-21FD3A59-7768-4DC4-9A25-28020E9976A8 Q36420157-8D90CAA3-EC9F-4738-BD26-65293FF553ED Q37486855-B72C191C-CFC6-4B5B-9A68-56AB9DE9626F Q37628285-8D2B0651-1CFA-4C3D-ADEA-B8A3EDA9A0A3 Q37968218-D2E71A3B-3360-4094-A107-2134892201A5 Q38490392-0293BB13-AD9D-416F-BA95-C689B98BBCDE Q38868504-87D18B22-D84C-4B49-9857-C45D79957372 Q47112812-A4E35EF0-A767-4AD0-913E-189F166ADE0D Q50439906-2A6D2E77-D190-4145-A8E3-0E7DB38B698F

P2860

Folic acid supplementation normalizes the endothelial progenitor cell transcriptome of patients with type 1 diabetes: a case-control pilot study.

http://www.wikidata.org/entity/Q37337753

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Folic acid supplementation nor ...... s: a case-control pilot study.

@en

Folic acid supplementation nor ...... s: a case-control pilot study.

@nl

type

label

Folic acid supplementation nor ...... s: a case-control pilot study.

@en

Folic acid supplementation nor ...... s: a case-control pilot study.

@nl

prefLabel

Folic acid supplementation nor ...... s: a case-control pilot study.

@en

Folic acid supplementation nor ...... s: a case-control pilot study.

@nl

P1433

Q37337753-F1AB99E0-9421-4B65-A4AF-B3E6C4DBB165

P1476

Q37337753-C9FA62CD-785F-424B-8CB1-5874E3803BBB

P2093

Q37337753-00261883-A85E-4661-9FE3-E2B732DE089A

Q37337753-06797551-B1DC-4A29-A1B3-18B1B1707C63

Q37337753-40FA25B0-0E12-4804-B394-DE54944F82CC

Q37337753-A1FBA176-AA64-4CD6-878E-666A55F8B8A8

Q37337753-A7BFF58F-90A7-4198-8630-9BC9AFE770EA

Q37337753-F8FB2E79-E7CB-4AE9-8CCD-AA230489D093

P2860

Q37337753-0082AF6E-1E08-4313-928D-A3DED8F9E9D7

Q37337753-025A9601-7A67-42B0-83F8-133C179084A0

Q37337753-0C239169-3110-46DC-BD0B-521B7100BDCC

Q37337753-0F743A78-3285-421D-B64B-7DE7AEAD640A

Q37337753-15776893-8FE3-4AB3-ABEE-D3CE83F4522B

Q37337753-169CEB1E-AE55-4DB9-A130-9D436892E24C

Q37337753-1A1D8AD6-EDB4-4F9C-AA6E-30E4CA666F96

Q37337753-1ECB1772-9C6D-4AA0-808C-D7E053FEFA5C

Q37337753-20B3BE8F-C1B6-4B82-B122-CEBAFD4E2C2A

Q37337753-2EB0A378-BAC8-4301-8B46-4C416629C002

P2888

Q37337753-BFA671FE-D6FC-4531-87EA-21D1CDA41130

P304

Q37337753-2DAC19EE-B49A-43C3-8781-6DFDB4BF188B

P31

Q37337753-4E8CDA0B-D661-48AB-8806-301E305617AA

P356

Q37337753-0F2FDB01-8E6C-493D-9CE0-1414FB50E030

P407

Q37337753-1491D2F5-4439-46DD-8310-9F96F6B7BBCA

P478

Q37337753-5DE5EF89-493E-4675-8BB5-68E42455BBFE

P50

Q37337753-9A8E5BD3-B62C-4B5C-A1DE-95EBACEA49F0

Q37337753-CFF2A765-C89C-447A-84FC-6C9B6C1E054A

Q37337753-D19E2BF5-029B-469B-9EBF-29AF68EA93ED

P577

Q37337753-FFFE441F-F443-451F-AF9A-36793AA2CFE6

P5875

Q37337753-F2C4AE6B-F0FB-47E4-B2F0-A217D72129B9

P6179

Q37337753-F2B440E1-7518-4D55-974B-848B2F29067D

P698

Q37337753-13A4015C-64DC-42A6-B0F6-8425B44FA398

P921

Q37337753-6CAD94EC-A1A5-43CC-861E-DE16BBB9011C

Q37337753-83276305-DD3D-4EBA-ABC3-65B69629E99A

Q37337753-D068B40C-1B69-4F7C-8054-3D695D87E95A

P932

Q37337753-D97FA74A-3389-4C51-93DB-770F27244D85

P356

P1433

Cardiovascular Diabetology

P1476

Folic acid supplementation nor ...... s: a case-control pilot study.

@en

P2093

Andrew Stubbs

http://www.w3.org/2001/XMLSchema#string

Attie Tuinenburg

http://www.w3.org/2001/XMLSchema#string

Dominique P V de Kleijn

http://www.w3.org/2001/XMLSchema#string

Mario Pescatori

http://www.w3.org/2001/XMLSchema#string

Olivia van Oostrom

http://www.w3.org/2001/XMLSchema#string

Sai Kiang Lim

http://www.w3.org/2001/XMLSchema#string

P2860

Id proteins in development, cell cycle and cancer

Id proteins at the cross-road of development and cancer

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes.

Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses.

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.

P2888

P304

47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-8-47

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Marianne C. Verhaar

Joost O Fledderus

Dominique P V de Kleijn

P577

2009-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26766237

http://www.w3.org/2001/XMLSchema#string

P6179

1033397649

http://www.w3.org/2001/XMLSchema#string

P698

19706161

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

2739843

http://www.w3.org/2001/XMLSchema#string